Cumulative incidence of cancer after solid organ transplantation

Cancer

Volumn 119, Issue 12, 2013, Pages 2300-2308

  Hall, Erin C ^a,b   Pfeiffer, Ruth M ^a   Segev, Dorry L ^b   Engels, Eric A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

absolute risk; non Hodgkin lymphoma; screening; transplantation

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CHILD; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HEART TRANSPLANTATION; HUMAN; INFANT; KIDNEY CANCER; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; ORGAN TRANSPLANTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSTATE CANCER; RECIPIENT; SCHOOL CHILD; SOLID ORGAN TRANSPLANTATION;

ADOLESCENT; ADULT; AGE FACTORS; BREAST NEOPLASMS; CHILD; CHILD, PRESCHOOL; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INFANT; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; LUNG NEOPLASMS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASMS; ORGAN TRANSPLANTATION; PROSTATIC NEOPLASMS; REGISTRIES; UNITED STATES; YOUNG ADULT;

EID: 84878523941     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28043     Document Type: Article

References (34)

1. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM,. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007; 370: 59-67.
2. Department of Health and Human Services, Health Resources and Services Administration. 2008 Annual Report of the US Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1998-2007. Rockville, MD: US Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2008.
3. Lau B, Cole SR, Gange SJ,. Competing risk regression models for epidemiologic data. Am J Epidemiol. 2009; 170: 244-256.
4. Pintilie M,. Competing Risks: A Practical Perspective. Chichester, United Kingdom: John Wiley & Sons, Ltd.; 2007.
5. Varadhan R, Weiss CO, Segal JB, Wu AW, Scharfstein D, Boyd C,. Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications. Med Care. 2010; 48 (6 suppl): S96-S105.
6. Engels EA, Pfeiffer RM, Fraumeni JF Jr, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011; 306: 1891-1901.
7. Coviello V, Boggess M,. Cumulative incidence estimation in the presence of competing risks [serial online]. Stata J. 2004; 4: 103e112.
8. Fine JP, Gray RJ,. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999; 94: 496-509.
9. Collett D, Mumford L, Banner NR, Neuberger J, Watson C,. Comparison of the incidence of malignancy in recipients of different types of organ: a UK registry audit. Am J Transplant. 2010; 10: 1889-1896.
10. Villeneuve PJ, Schaubel DE, Fenton SS, Shepherd FA, Jiang Y, Mao Y,. Cancer incidence among Canadian kidney transplant recipients. Am J Transplant. 2007; 7: 941-948.
11. Harris NL, Ferry JA, Swerdlow SH,. Post-transplant lymphoproliferative disorders: summary of Society for Hematopathology workshop. Semin Diagn Pathol. 1997; 14: 8-14.
12. Dharnidharka VR, Lamb KE, Gregg JA, Meier-Kriesche HU,. Associations between EBV serostatus and organ transplant type in PTLD risk: an analysis of the SRTR National Registry Data in the United States. Am J Transplant. 2012; 12: 976-983.
13. Opelz G, Daniel V, Naujokat C, Dohler B,. Epidemiology of pretransplant EBV and CMV serostatus in relation to post-transplant non-Hodgkin lymphoma. Transplantation. 2009; 88: 962-967.
14. Gregorek H, Jankowska I, Dzierzanowska-Fangrat K, et al. Long-term monitoring of Epstein-Barr virus DNA load and humoral parameter abnormalities in pediatric liver transplant recipients before development of malignancy. Pediatr Transplant. 2010; 14: 629-635.
15. Swerdlow AJ, Higgins CD, Hunt BJ, et al. Risk of lymphoid neoplasia after cardiothoracic transplantation. A cohort study of the relation to Epstein-Barr virus. Transplantation. 2000; 69: 897-904.
16. Minai OA, Shah S, Mazzone P, et al. Bronchogenic carcinoma after lung transplantation: characteristics and outcomes. J Thorac Oncol. 2008; 3: 1404-1409.
17. Dickson RP, Davis RD, Rea JB, Palmer SM,. High frequency of bronchogenic carcinoma after single-lung transplantation. J Heart Lung Transplant. 2006; 25: 1297-1301.
18. Engels EA,. Inflammation in the development of lung cancer: epidemiological evidence. Expert Rev Anticancer Ther. 2008; 8: 605-615.
19. Botha P, Peaston R, White K, Forty J, Dark JH, Parry G,. Smoking after cardiac transplantation. Am J Transplant. 2008; 8: 866-871.
20. Vos R, De Vusser K, Schaevers V, et al. Smoking resumption after lung transplantation: a sobering truth. Eur Respir J. 2010; 35: 1411-1413.
21. National Lung Screening Trial Research Team;, Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365: 395-409.
22. Goh A, Vathsala A,. Native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients. Am J Transplant. 2011; 11: 86-92.
23. Heinz-Peer G, Schoder M, Rand T, Mayer G, Mostbeck GH,. Prevalence of acquired cystic kidney disease and tumors in native kidneys of renal transplant recipients: a prospective US study. Radiology. 1995; 195: 667-671.
24. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009; 9 (suppl 3): S1-S155.
25. Wong G, Howard K, Webster AC, Chapman JR, Craig JC,. Screening for renal cancer in recipients of kidney transplants. Nephrol Dial Transplant. 2011; 26: 1729-1739.
26. US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2008; 149: 627-637.
27. US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009; 151: 716-726, W-236.
28. Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW,. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2010; 60: 99-119.
29. Kiberd BA, Keough-Ryan T, Clase CM,. Screening for prostate, breast and colorectal cancer in renal transplant recipients. Am J Transplant. 2003; 3: 619-625.
30. Alam M, Brown RN, Silber DH, et al. Increased incidence and mortality associated with skin cancers after cardiac transplant. Am J Transplant. 2011; 11: 1488-1497.
31. Krynitz B, Edgren G, Lindelof B, et al. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008-A Swedish population-based study. Int J Cancer. 2013; 132: 1429-1438.
32. Hofbauer GF, Anliker M, Arnold A, et al. Swiss clinical practice guidelines for skin cancer in organ transplant recipients. Swiss Med Wkly. 2009; 139: 407-415.
33. Traywick C, O'Reilly FM,. Management of skin cancer in solid organ transplant recipients. Dermatol Ther. 2005; 18: 12-18.
34. Zwald FO, Brown M,. Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients. J Am Acad Dermatol. 2011; 65: 263-279; quiz 280.